Table 1:

Baseline characteristics between sulcal SAH versus non-sulcal SAHa

Total (n = 209)Sulcal SAH (n = 33)Non-Sulcal SAH (n = 176)P Value
Age (mean) (yr)69.9 (SD, 12.4)73.1 (SD, 11.2)69.3 (SD, 12.6).104
Male110 (56.9)16 (48.5)103 (58.5).38
Risk factor
 Hypertension139 (66.5)21 (63.6)118 (67.0).857
 Diabetes71 (34.0)13 (39.4)58 (33.0).606
 Dyslipidemia53 (25.4)11 (33.3)42 (23.9).353
 Smoking43 (20.6)10 (30.3)33 (18.8).203
 Coronary artery disease21 (10.0)3 (9.1)18 (10.2)1.0
 Atrial fibrillation97 (46.4)13 (39.4)84 (47.7).49
 Previous stroke30 (14.4)4 (12.1)26 (14.8).898
Etiology of occlusion
 Thromboembolic180 (86.1)29 (87.9)151 (85.8).999
 In-situ thrombosis27 (12.9)3 (9.1)24 (13.6).583
Intravenous tPA44 (21.1)6 (18.2)38 (21.6).835
Prestroke mRS0 (0–1)0 (0–0)0 (0–1).85
Admission NIHSSb10 (7–15)11 (7–15)10 (7–15).953
ASPECTSb9 (8–10)9 (8–9)9 (8–10).764
Occlusion site<.001
 Proximal146 (69.9)10 (30.3)136 (77.3)
 Distal63 (30.1)23 (69.7)40 (22.7)
Division.064
 Superior98 (46.9)21 (63.6)77 (43.8)
 Inferior106 (50.7)11 (33.3)95 (54.0)
 Middle5 (2.4)1 (3.0)4 (2.3)
  • a Data are presented as number (%) except where otherwise noted.

  • b Data are median, and numbers in parentheses are interquartile range.